Headlines about Ventas (NYSE:VTR) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Ventas earned a media sentiment score of 0.05 on Accern’s scale. Accern also gave media coverage about the real estate investment trust an impact score of 47.0730737771901 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Here are some of the news headlines that may have effected Accern’s analysis:
- Ventas, Inc. (VTR) Receives Consensus Rating of “Hold” from Brokerages (americanbankingnews.com)
- Ventas (VTR) Raised to Buy at ValuEngine (americanbankingnews.com)
- The Implied Analyst 12-Month Target For ICF (nasdaq.com)
- Is the Stock In Play?: Ventas Inc (NYSE: VTR) – Alpha Beta Stock (alphabetastock.com)
- Will These Stocks Remain Hot? Ventas, Inc. (VTR), Sangamo Therapeutics, Inc. (SGMO) – Market Movers (financialqz.com)
A number of research analysts recently commented on VTR shares. KeyCorp reissued a “sell” rating and issued a $55.00 target price on shares of Ventas in a research note on Sunday, September 17th. Bank of America cut Ventas from a “buy” rating to a “neutral” rating and reduced their target price for the company from $72.00 to $71.00 in a research note on Friday, September 22nd. Capital One Financial started coverage on Ventas in a research note on Monday, September 25th. They issued an “equal weight” rating and a $69.00 target price on the stock. UBS Group reduced their target price on Ventas from $69.00 to $66.00 and set a “neutral” rating on the stock in a research note on Monday, October 2nd. Finally, BMO Capital Markets reissued a “sell” rating and issued a $62.00 target price on shares of Ventas in a research note on Wednesday, October 18th. Eight equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and three have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $64.44.
Ventas (NYSE:VTR) last posted its quarterly earnings results on Friday, October 27th. The real estate investment trust reported $0.44 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.04 by ($0.60). Ventas had a net margin of 32.96% and a return on equity of 6.34%. The business had revenue of $899.90 million for the quarter, compared to analysts’ expectations of $893.18 million. During the same quarter in the previous year, the company earned $1.03 earnings per share. The business’s quarterly revenue was up 3.8% on a year-over-year basis. equities analysts expect that Ventas will post 4.16 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 12th. Shareholders of record on Tuesday, January 2nd will be given a dividend of $0.79 per share. This represents a $3.16 annualized dividend and a yield of 5.56%. This is a positive change from Ventas’s previous quarterly dividend of $0.78. The ex-dividend date is Friday, December 29th. Ventas’s dividend payout ratio is presently 188.10%.
Ventas, Inc is a real estate investment trust (REIT) with its properties located throughout the United States, Canada and the United Kingdom. The Company operates through three segments: triple-net leased properties, senior living operations and office operations. Under its triple-net leased properties segment, the Company invests in and owns seniors housing and healthcare properties throughout the United States and the United Kingdom and leases those properties to healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses.
What are top analysts saying about Ventas? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Ventas and related companies.